Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2025-12-26 @ 3:53 AM
Study NCT ID:
NCT06928818
Status:
RECRUITING
Last Update Posted:
2025-04-17
First Post:
2025-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
Sponsor:
Seoul National University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2028-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-31
First Submit QC Date:
None
Study First Post Date:
2025-04-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-14
Last Update Post Date:
2025-04-17
Last Update Post Date Type:
ACTUAL